Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide

Background: forgiveness is the ability of a given regimen to maintain complete viral suppression despite a documented imperfect adherence. We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide. Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggiolo, Franco, Valenti, Daniela, Teocchi, Rodolfo, Comi, Laura, Di Filippo, Elisa, Rizzi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703486/
https://www.ncbi.nlm.nih.gov/pubmed/36423244
http://dx.doi.org/10.1177/23259582221140208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703486/
https://www.ncbi.nlm.nih.gov/pubmed/36423244
http://dx.doi.org/10.1177/23259582221140208

Ejemplares similares